Calendar
November 2010 December 2010 January 2011
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
There are no upcoming events currently scheduled.
View full calendar
"Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)." PDF Print

On Thursday, September 30, 2010, the Committee on Oversight and Government Reform held a hearing entitled, "Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)." This is the second hearing examining the circumstances surrounding the April 30, 2010, recall of more than 135 million bottles of Children's Tylenol and other popular pediatric medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. The first hearing was held on May 27, 2010. This hearing will focus on both the broader recall announced in April of this year and on the "phantom recall" of an adult Motrin product that came to light as a result of the first hearing.

 

The hearing took place at 10:00 a.m. in room HVC-210 of the Capitol Visitor Center.

To watch a webcast of the hearing, please click
here.

 

Panel I:

 

William C. Weldon

Chairman and Chief Executive Officer

Johnson & Johnson

Colleen Goggins

Worldwide Chairman, Consumer Group

Johnson & Johnson

Panel II:

 

Joshua M. Sharfstein, M.D.

Principal Deputy Commissioner
Food and Drug Administration (FDA)

 

Documents and Links

Opening Statement of Chairman Edolphus Towns  
Testimony of William Weldon

Testimony of Colleen Goggins
Testimony of Joshua Sharfstein
Chairman Towns Introduces Legislation to Provide the FDA Mandatory Recall Authority (Press Release: July 15, 2010)
Closing Remarks of Chairman Edolphus Towns

 

 

Committee On Oversight and Government Reform

U.S. House of Representatives | 2157 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051